Download PDF
CC BY 4.0 · Thromb Haemost 2020; 120(02): 253-261
DOI: 10.1055/s-0039-3400305
Cellular Haemostasis and Platelets
Georg Thieme Verlag KG Stuttgart · New York

Hypoxia Modulates Platelet Purinergic Signalling Pathways

Gordon G. Paterson
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Jason M. Young
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Joseph A. Willson
3   University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
,
Christopher J. Graham 
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Rebecca C. Dru
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Eleanor W. Lee
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Greig S. Torpey
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
2   Edinburgh Medical School, University of Edinburgh, Edinburgh, United Kingdom
,
Sarah R. Walmsley
3   University of Edinburgh Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
,
Melissa V. Chan
4   Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
,
Timothy D. Warner 
4   Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
,
John Kenneth Baillie
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
5   Division of Genetics and Genomics, The Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom
6   Department of Anaesthesia, Critical Care and Pain Medicine, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom
,
Alfred Arthur Roger Thompson 
1   APEX (Altitude Physiology Expeditions), Edinburgh, United Kingdom
7   Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
› Author Affiliations Funding This study received funding from the Wilderness Medical Society Charles S. Houston Grant, supported by the Academy of Wilderness Medicine. It also received funding from British Heart Foundation, (Grant/Award Number: ‘FS/18/13/3328’,‘PG/15/47/31591’), Wilderness Medicine Society (Grant/Award Number: ‘Charles S. Houston grant’) and Wellcome Trust, (Grant/Award Number: ‘103258/Z/13/Z,A’).
Further Information

Publication History

24 April 2019

29 September 2019

Publication Date:
13 December 2019 (online)

   Permissions and Reprints

Abstract

Background Hypoxia resulting from ascent to high-altitude or pathological states at sea level is known to increase platelet reactivity. Previous work from our group has suggested that this may be adenosine diphosphate (ADP)-specific. Given the clinical importance of drugs targeting ADP pathways, research into the impact of hypoxia on platelet ADP pathways is highly important.

Methods Optimul aggregometry was performed on plasma from 29 lowland residents ascending to 4,700 m, allowing systematic assessment of platelet reactivity in response to several platelet agonists. Aggregometry was also performed in response to ADP in the presence of inhibitors of the two main ADP receptors, P2Y1 and P2Y12 (MRS2500 and cangrelor, respectively). Phosphorylation of vasodilator-stimulated phosphoprotein (VASP), a key determinant of platelet aggregation, was analysed using the VASPFix assay.

Results Hypobaric hypoxia significantly reduced the ability of a fixed concentration of cangrelor to inhibit ADP-induced aggregation and increased basal VASP phosphorylation. However, in the absence of P2Y receptor inhibitors, we did not find evidence of increased platelet sensitivity to any of the agonists tested and found reduced sensitivity to thrombin receptor-activating peptide-6 amide.

Conclusion Our results provide evidence of increased P2Y1 receptor activity at high altitude and suggest down-regulation of the P2Y12 pathway through increased VASP phosphorylation. These changes in ADP pathway activity are of potential therapeutic significance to high-altitude sojourners and hypoxic sea level patients prescribed platelet inhibitors and warrant further investigation.

Keywords

hypoxia - platelet physiology - anti-platelet agents - ADP receptors - high altitude

Authors' Contributions

G.G.P., M.V.C., T.D.W. and A.A.R.T. conceived the study and designed the experiments; G.G.P., J.M.Y., J.A.W., C.J.G., R.C.D., E.W.L., G.S.T., M.V.C. and S.R.W. performed experiments and assisted with logistics; G.G.P., M.V.C., T.D.W., J.K.B. and A.A.R.T. analysed and interpreted the data; G.G.P. and A.A.R.T. drafted the manuscript with contributions from all authors.


Supplementary Material

 

  • References

  • 1 Bärtsch P. How thrombogenic is hypoxia?. JAMA 2006; 295 (19) 2297-2299
    CrossrefPubMedGoogle Scholar
  • 2 Anand AC, Jha SK, Saha A, Sharma V, Adya CM. Thrombosis as a complication of extended stay at high altitude. Natl Med J India 2001; 14 (04) 197-201
    PubMedGoogle Scholar
  • 3 Jha SK, Anand AC, Sharma V, Kumar N, Adya CM. Stroke at high altitude: Indian experience. High Alt Med Biol 2002; 3 (01) 21-27
    CrossrefPubMedGoogle Scholar
  • 4 Schaber M, Leichtfried V, Fries D. , et al. Influence of acute normobaric hypoxia on hemostasis in volunteers with and without acute mountain sickness. BioMed Res Int 2015; 2015: 593938
    PubMedGoogle Scholar
  • 5 Toff WD, Jones CI, Ford I. , et al. Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation. JAMA 2006; 295 (19) 2251-2261
    CrossrefPubMedGoogle Scholar
  • 6 Rocke AS, Paterson GG, Barber MT. , et al. Thromboelastometry and platelet function during acclimatization to high altitude. Thromb Haemost 2018; 118 (01) 63-71
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Pichler Hefti J, Risch L, Hefti U. , et al. Changes of coagulation parameters during high altitude expedition. Swiss Med Wkly 2010; 140 (7-8): 111-117
    PubMedGoogle Scholar
  • 8 Ninivaggi M, de Laat M, Lancé MMD. , et al. Hypoxia induces a prothrombotic state independently of the physical activity. PLoS One 2015; 10: e0141797
    CrossrefPubMedGoogle Scholar
  • 9 Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011; 9 (Suppl. 01) 92-104
    PubMedGoogle Scholar
  • 10 Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 2009; 102 (02) 248-257
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Lehmann T, Mairbäurl H, Pleisch B, Maggiorini M, Bärtsch P, Reinhart WH. Platelet count and function at high altitude and in high-altitude pulmonary edema. J Appl Physiol (1985) 2006; 100 (02) 690-694
    CrossrefPubMedGoogle Scholar
  • 12 Tyagi T, Ahmad S, Gupta N. , et al. Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood 2014; 123 (08) 1250-1260
    CrossrefPubMedGoogle Scholar
  • 13 Fox JE, Taylor RG, Taffarel M, Boyles JK, Goll DE. Evidence that activation of platelet calpain is induced as a consequence of binding of adhesive ligand to the integrin, glycoprotein IIb-IIIa. J Cell Biol 1993; 120 (06) 1501-1507
    CrossrefPubMedGoogle Scholar
  • 14 Jacobson KA, Deflorian F, Mishra S, Costanzi S. Pharmacochemistry of the platelet purinergic receptors. Purinergic Signal 2011; 7 (03) 305-324
    CrossrefPubMedGoogle Scholar
  • 15 Keyes LE, Mather L, Duke C. , et al. Older age, chronic medical conditions and polypharmacy in Himalayan trekkers in Nepal: an epidemiologic survey and case series. J Travel Med 2016; 23 (06) 1-6
    CrossrefPubMedGoogle Scholar
  • 16 Chan MV, Warner TD. Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readings. Platelets 2012; 23 (05) 404-408
    CrossrefPubMedGoogle Scholar
  • 17 Butt E, Abel K, Krieger M. , et al. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 1994; 269 (20) 14509-14517
    CrossrefPubMedGoogle Scholar
  • 18 Hollopeter G, Jantzen H-M, Vincent D. , et al. Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 2001; 409 (6817): 202-207
    CrossrefPubMedGoogle Scholar
  • 19 Schwarz UR, Geiger J, Walter U, Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets--definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 1999; 82 (03) 1145-1152
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Glenn JR, Dovlatova N, White AE, Dhillon K, Heptinstall S, Fox SC. ‘VASPFix’ for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists. Thromb Haemost 2014; 111 (03) 539-548
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Belsley DA, Kuh E, Welsch RE. Detecting Influential Observations and Outliers. In: Regression Diagnostics: Identifying Influential Data and Sources of Collinearity. Hoboken: John Wiley & Sons, Inc; 1980: 6-84
    Google Scholar
  • 22 Jones E, Oliphant T, Peterson P. , et al. SciPy: open source scientific tools for Python [Internet]. 2001 . Available at: http://www.scipy.org/ . Accessed October 16, 2019
    PubMedGoogle Scholar
  • 23 R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria: [Internet]. 2019. . Available at: http://www.r-project.org/ . Accessed October 16, 2019
    Google Scholar
  • 24 Würtz M, Hvas A-M, Kristensen SD, Grove EL. Platelet aggregation is dependent on platelet count in patients with coronary artery disease. Thromb Res 2012; 129 (01) 56-61
    CrossrefPubMedGoogle Scholar
  • 25 Chan MV, Armstrong PCJ, Papalia F, Kirkby NS, Warner TD. Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testing. Platelets 2011; 22 (07) 485-494
    CrossrefPubMedGoogle Scholar
  • 26 Würtz M, Hvas A-M, Christensen KH, Rubak P, Kristensen SD, Grove EL. Rapid evaluation of platelet function using the Multiplate® Analyzer. Platelets 2014; 25 (08) 628-633
    CrossrefPubMedGoogle Scholar
  • 27 Beck F, Geiger J, Gambaryan S. , et al. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood 2017; 129 (02) e1-e12
    CrossrefPubMedGoogle Scholar
  • 28 Nisar S, Kelly E, Cullen PJ, Mundell SJ. Regulation of P2Y1 receptor traffic by sorting Nexin 1 is retromer independent. Traffic 2010; 11 (04) 508-519
    CrossrefPubMedGoogle Scholar
  • 29 Magalhaes AC, Dunn H, Ferguson SS. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins. Br J Pharmacol 2012; 165 (06) 1717-1736
    CrossrefPubMedGoogle Scholar
  • 30 Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273 (04) 2030-2034
    CrossrefPubMedGoogle Scholar
  • 31 Grocott M, Montgomery H, Vercueil A. High-altitude physiology and pathophysiology: implications and relevance for intensive care medicine. Crit Care 2007; 11 (01) 203
    CrossrefPubMedGoogle Scholar
  • 32 Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65 (11) 956-962
    CrossrefPubMedGoogle Scholar
  • 33 Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464): 1046-1053
    CrossrefPubMedGoogle Scholar
  • 34 Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16 (04) 648-652
    CrossrefPubMedGoogle Scholar
  • 35 Maclay JD, McAllister DA, Johnston S. , et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011; 66 (09) 769-774
    CrossrefPubMedGoogle Scholar
  • 36 Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995; 108 (03) 625-630
    CrossrefPubMedGoogle Scholar
  • 37 Qureshi Z, Hobson AR. Clopidogrel “resistance”: where are we now?. Cardiovasc Ther 2013; 31 (01) 3-11
    CrossrefPubMedGoogle Scholar
  • 38 Topçuoglu MA, Arsava EM, Ay H. Antiplatelet resistance in stroke. Expert Rev Neurother 2011; 11 (02) 251-263
    CrossrefPubMedGoogle Scholar
  • 39 Jha PK, Sahu A, Prabhakar A. , et al. Genome-wide expression analysis suggests hypoxia-triggered hyper-coagulation leading to venous thrombosis at high altitude. Thromb Haemost 2018; 118 (07) 1279-1295
    Article in Thieme ConnectPubMedGoogle Scholar
  • 40 Duplain H, Sartori C, Lepori M. , et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation. Am J Respir Crit Care Med 2000; 162 (01) 221-224
    CrossrefPubMedGoogle Scholar
  • 41 Levett DZ, Fernandez BO, Riley HL. , et al; Caudwell Extreme Everest Research Group. The role of nitrogen oxides in human adaptation to hypoxia. Sci Rep 2011; 1: 109
    CrossrefPubMedGoogle Scholar
  • 42 Massberg S, Grüner S, Konrad I. , et al. Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 2004; 103 (01) 136-142
    CrossrefPubMedGoogle Scholar
  • 43 Srihirun S, Piknova B, Sibmooh N. , et al. Phosphorylated vasodilator-stimulated phosphoprotein (P-VASPSer239) in platelets is increased by nitrite and partially deoxygenated erythrocytes. PLoS One 2018; 13: e0193747
    CrossrefPubMedGoogle Scholar
  • 44 Webb AJ, Milsom AB, Rathod KS. , et al. Mechanisms underlying erythrocyte and endothelial nitrite reduction to nitric oxide in hypoxia: role for xanthine oxidoreductase and endothelial nitric oxide synthase. Circ Res 2008; 103 (09) 957-964
    CrossrefPubMedGoogle Scholar
  • 45 Versteeg HH, Heemskerk JWM, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (01) 327-358
    CrossrefPubMedGoogle Scholar
  • 46 Kiouptsi K, Gambaryan S, Walter E, Walter U, Jurk K, Reinhardt C. Hypoxia impairs agonist-induced integrin αIIbβ3 activation and platelet aggregation. Sci Rep 2017; 7 (01) 7621
    CrossrefPubMedGoogle Scholar
  • 47 Kauffenstein G, Bergmeier W, Eckly A. , et al. The P2Y(12) receptor induces platelet aggregation through weak activation of the α(IIb)β(3) integrin--a phosphoinositide 3-kinase-dependent mechanism. FEBS Lett 2001; 505 (02) 281-290
    CrossrefPubMedGoogle Scholar
  • 48 Kamae T, Shiraga M, Kashiwagi H. , et al. Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation. J Thromb Haemost 2006; 4 (06) 1379-1387
    CrossrefPubMedGoogle Scholar
  • 49 Horstrup K, Jablonka B, Hönig-Liedl P, Just M, Kochsiek K, Walter U. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition. Eur J Biochem 1994; 225 (01) 21-27
    CrossrefPubMedGoogle Scholar
  • 50 Caradec J, Sirab N, Keumeugni C. , et al. ‘Desperate house genes’: the dramatic example of hypoxia. Br J Cancer 2010; 102 (06) 1037-1043
    CrossrefPubMedGoogle Scholar
  • 51 Becker DM, Segal J, Vaidya D. , et al. Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 2006; 295 (12) 1420-1427
    CrossrefPubMedGoogle Scholar